Similarly, known CL-dependent HNF4α hepatic target genes were not altered in our model of WD, thus suggesting that the WAT lipolysis-dependent activity of hepatic HNF4α is also intact in MASLD. Here, HNF4A is linked to metabolic dysfunction-associated steatotic liver disease.